English
简体中文
Total: £ 56.28
Published Date: 2024-09-13 | Pages: 127 | Tables: 249 | Pharma & Healthcare
Glucose Injection solution is used in hospitalized patients for nutrition support, to treat low blood sugar, and to decrease high potassium levels in the blood.
The global market for Glucose Injection was estimated to be worth US$ 3140 million in 2023 and is forecast to a readjusted size of US$ 6531.5 million by 2030 with a CAGR of 10.8% during the forecast period 2024-2030
According to the "Global Use of Medicines 2023" released by IQVIA Institute, global pharmaceutical expenditures in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and are forecast to grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America and Japan are expected to grow at a slower rate in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America and Eastern Europe will grow strongly. In terms of drug spending, China's drug spending in 2022 will be approximately US$166 billion. It is expected that drug expenditures will only increase in the next few years: from the perspective of demand, the trend of population aging, the increase in residents' wealth and the improvement of health awareness will drive the demand for drugs; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has been elevated to a national strategy; from the perspective of industry policies, it has experienced the uncertainty caused by the early stage of pharmaceutical reform, the implementation of centralized procurement policies and the revision of the drug reimbursement catalog The update will gradually achieve a dynamic balance with multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the public.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucose Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Glucose Injection by region & country, by Type, and by Application.
The Glucose Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucose Injection.
Market Segmentation
By Company
Pfizer
Amphastar
ChanGee
HAIXIN
SSY Group
CR Double-Cran
Otsuka
B. Braun Medical Inc
ICU Medical
Baxter
Fresenius Kabi
Segment by Type:
5% Injection
10% Injection
50% Injection
70% Injection
Other
Segment by Application
Sports
First-Aid Treatment
Trophotherapy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Glucose Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Glucose Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Glucose Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Glucose Injection Product Introduction
1.2 Global Glucose Injection Market Size Forecast
1.2.1 Global Glucose Injection Sales Value (2019-2030)
1.2.2 Global Glucose Injection Sales Volume (2019-2030)
1.2.3 Global Glucose Injection Sales Price (2019-2030)
1.3 Glucose Injection Market Trends & Drivers
1.3.1 Glucose Injection Industry Trends
1.3.2 Glucose Injection Market Drivers & Opportunity
1.3.3 Glucose Injection Market Challenges
1.3.4 Glucose Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Glucose Injection Players Revenue Ranking (2023)
2.2 Global Glucose Injection Revenue by Company (2019-2024)
2.3 Global Glucose Injection Players Sales Volume Ranking (2023)
2.4 Global Glucose Injection Sales Volume by Company Players (2019-2024)
2.5 Global Glucose Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers Glucose Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Glucose Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Glucose Injection
2.9 Glucose Injection Market Competitive Analysis
2.9.1 Glucose Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Glucose Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucose Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 5% Injection
3.1.2 10% Injection
3.1.3 50% Injection
3.1.4 70% Injection
3.1.5 Other
3.2 Global Glucose Injection Sales Value by Type
3.2.1 Global Glucose Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Glucose Injection Sales Value, by Type (2019-2030)
3.2.3 Global Glucose Injection Sales Value, by Type (%) (2019-2030)
3.3 Global Glucose Injection Sales Volume by Type
3.3.1 Global Glucose Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Glucose Injection Sales Volume, by Type (2019-2030)
3.3.3 Global Glucose Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global Glucose Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Sports
4.1.2 First-Aid Treatment
4.1.3 Trophotherapy
4.1.4 Other
4.2 Global Glucose Injection Sales Value by Application
4.2.1 Global Glucose Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Glucose Injection Sales Value, by Application (2019-2030)
4.2.3 Global Glucose Injection Sales Value, by Application (%) (2019-2030)
4.3 Global Glucose Injection Sales Volume by Application
4.3.1 Global Glucose Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Glucose Injection Sales Volume, by Application (2019-2030)
4.3.3 Global Glucose Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global Glucose Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Glucose Injection Sales Value by Region
5.1.1 Global Glucose Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Glucose Injection Sales Value by Region (2019-2024)
5.1.3 Global Glucose Injection Sales Value by Region (2025-2030)
5.1.4 Global Glucose Injection Sales Value by Region (%), (2019-2030)
5.2 Global Glucose Injection Sales Volume by Region
5.2.1 Global Glucose Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Glucose Injection Sales Volume by Region (2019-2024)
5.2.3 Global Glucose Injection Sales Volume by Region (2025-2030)
5.2.4 Global Glucose Injection Sales Volume by Region (%), (2019-2030)
5.3 Global Glucose Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Glucose Injection Sales Value, 2019-2030
5.4.2 North America Glucose Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Glucose Injection Sales Value, 2019-2030
5.5.2 Europe Glucose Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Glucose Injection Sales Value, 2019-2030
5.6.2 Asia Pacific Glucose Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Glucose Injection Sales Value, 2019-2030
5.7.2 South America Glucose Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Glucose Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa Glucose Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Glucose Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Glucose Injection Sales Value
6.2.1 Key Countries/Regions Glucose Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions Glucose Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Glucose Injection Sales Value, 2019-2030
6.3.2 United States Glucose Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Glucose Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Glucose Injection Sales Value, 2019-2030
6.4.2 Europe Glucose Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Glucose Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Glucose Injection Sales Value, 2019-2030
6.5.2 China Glucose Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Glucose Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Glucose Injection Sales Value, 2019-2030
6.6.2 Japan Glucose Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Glucose Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Glucose Injection Sales Value, 2019-2030
6.7.2 South Korea Glucose Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Glucose Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Glucose Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Glucose Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Glucose Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Glucose Injection Sales Value, 2019-2030
6.9.2 India Glucose Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Glucose Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Glucose Injection Product Offerings
7.1.5 Pfizer Recent Development
7.2 Amphastar
7.2.1 Amphastar Company Information
7.2.2 Amphastar Introduction and Business Overview
7.2.3 Amphastar Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Amphastar Glucose Injection Product Offerings
7.2.5 Amphastar Recent Development
7.3 ChanGee
7.3.1 ChanGee Company Information
7.3.2 ChanGee Introduction and Business Overview
7.3.3 ChanGee Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 ChanGee Glucose Injection Product Offerings
7.3.5 ChanGee Recent Development
7.4 HAIXIN
7.4.1 HAIXIN Company Information
7.4.2 HAIXIN Introduction and Business Overview
7.4.3 HAIXIN Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 HAIXIN Glucose Injection Product Offerings
7.4.5 HAIXIN Recent Development
7.5 SSY Group
7.5.1 SSY Group Company Information
7.5.2 SSY Group Introduction and Business Overview
7.5.3 SSY Group Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 SSY Group Glucose Injection Product Offerings
7.5.5 SSY Group Recent Development
7.6 CR Double-Cran
7.6.1 CR Double-Cran Company Information
7.6.2 CR Double-Cran Introduction and Business Overview
7.6.3 CR Double-Cran Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.6.4 CR Double-Cran Glucose Injection Product Offerings
7.6.5 CR Double-Cran Recent Development
7.7 Otsuka
7.7.1 Otsuka Company Information
7.7.2 Otsuka Introduction and Business Overview
7.7.3 Otsuka Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Otsuka Glucose Injection Product Offerings
7.7.5 Otsuka Recent Development
7.8 B. Braun Medical Inc
7.8.1 B. Braun Medical Inc Company Information
7.8.2 B. Braun Medical Inc Introduction and Business Overview
7.8.3 B. Braun Medical Inc Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.8.4 B. Braun Medical Inc Glucose Injection Product Offerings
7.8.5 B. Braun Medical Inc Recent Development
7.9 ICU Medical
7.9.1 ICU Medical Company Information
7.9.2 ICU Medical Introduction and Business Overview
7.9.3 ICU Medical Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.9.4 ICU Medical Glucose Injection Product Offerings
7.9.5 ICU Medical Recent Development
7.10 Baxter
7.10.1 Baxter Company Information
7.10.2 Baxter Introduction and Business Overview
7.10.3 Baxter Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Baxter Glucose Injection Product Offerings
7.10.5 Baxter Recent Development
7.11 Fresenius Kabi
7.11.1 Fresenius Kabi Company Information
7.11.2 Fresenius Kabi Introduction and Business Overview
7.11.3 Fresenius Kabi Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Fresenius Kabi Glucose Injection Product Offerings
7.11.5 Fresenius Kabi Recent Development
8 Industry Chain Analysis
8.1 Glucose Injection Industrial Chain
8.2 Glucose Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Glucose Injection Sales Model
8.5.2 Sales Channel
8.5.3 Glucose Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Glucose Injection Market Trends
Table 2. Glucose Injection Market Drivers & Opportunity
Table 3. Glucose Injection Market Challenges
Table 4. Glucose Injection Market Restraints
Table 5. Global Glucose Injection Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Glucose Injection Revenue Market Share by Company (2019-2024)
Table 7. Global Glucose Injection Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Glucose Injection Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Glucose Injection Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Glucose Injection Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Glucose Injection Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Glucose Injection
Table 13. Global Glucose Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucose Injection as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Glucose Injection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Glucose Injection Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Glucose Injection Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Glucose Injection Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Glucose Injection Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Glucose Injection Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Glucose Injection Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Glucose Injection Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Glucose Injection Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Glucose Injection Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Glucose Injection Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Glucose Injection Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Glucose Injection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Glucose Injection Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Glucose Injection Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Glucose Injection Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Glucose Injection Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Glucose Injection Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Glucose Injection Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Glucose Injection Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Glucose Injection Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Glucose Injection Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Glucose Injection Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Glucose Injection Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Glucose Injection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Glucose Injection Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Glucose Injection Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Glucose Injection Sales Value by Region (2019-2024) & (%)
Table 44. Global Glucose Injection Sales Value by Region (2025-2030) & (%)
Table 45. Global Glucose Injection Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Glucose Injection Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Glucose Injection Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Glucose Injection Sales Volume by Region (2019-2024) & (%)
Table 49. Global Glucose Injection Sales Volume by Region (2025-2030) & (%)
Table 50. Global Glucose Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Glucose Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Glucose Injection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Glucose Injection Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Glucose Injection Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Glucose Injection Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Glucose Injection Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer Company Information
Table 58. Pfizer Introduction and Business Overview
Table 59. Pfizer Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Pfizer Glucose Injection Product Offerings
Table 61. Pfizer Recent Development
Table 62. Amphastar Company Information
Table 63. Amphastar Introduction and Business Overview
Table 64. Amphastar Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Amphastar Glucose Injection Product Offerings
Table 66. Amphastar Recent Development
Table 67. ChanGee Company Information
Table 68. ChanGee Introduction and Business Overview
Table 69. ChanGee Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. ChanGee Glucose Injection Product Offerings
Table 71. ChanGee Recent Development
Table 72. HAIXIN Company Information
Table 73. HAIXIN Introduction and Business Overview
Table 74. HAIXIN Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. HAIXIN Glucose Injection Product Offerings
Table 76. HAIXIN Recent Development
Table 77. SSY Group Company Information
Table 78. SSY Group Introduction and Business Overview
Table 79. SSY Group Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. SSY Group Glucose Injection Product Offerings
Table 81. SSY Group Recent Development
Table 82. CR Double-Cran Company Information
Table 83. CR Double-Cran Introduction and Business Overview
Table 84. CR Double-Cran Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. CR Double-Cran Glucose Injection Product Offerings
Table 86. CR Double-Cran Recent Development
Table 87. Otsuka Company Information
Table 88. Otsuka Introduction and Business Overview
Table 89. Otsuka Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Otsuka Glucose Injection Product Offerings
Table 91. Otsuka Recent Development
Table 92. B. Braun Medical Inc Company Information
Table 93. B. Braun Medical Inc Introduction and Business Overview
Table 94. B. Braun Medical Inc Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. B. Braun Medical Inc Glucose Injection Product Offerings
Table 96. B. Braun Medical Inc Recent Development
Table 97. ICU Medical Company Information
Table 98. ICU Medical Introduction and Business Overview
Table 99. ICU Medical Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. ICU Medical Glucose Injection Product Offerings
Table 101. ICU Medical Recent Development
Table 102. Baxter Company Information
Table 103. Baxter Introduction and Business Overview
Table 104. Baxter Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Baxter Glucose Injection Product Offerings
Table 106. Baxter Recent Development
Table 107. Fresenius Kabi Company Information
Table 108. Fresenius Kabi Introduction and Business Overview
Table 109. Fresenius Kabi Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Fresenius Kabi Glucose Injection Product Offerings
Table 111. Fresenius Kabi Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Glucose Injection Downstream Customers
Table 115. Glucose Injection Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucose Injection Product Picture
Figure 2. Global Glucose Injection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Glucose Injection Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Glucose Injection Sales Volume (2019-2030) & (K Units)
Figure 5. Global Glucose Injection Sales Price (2019-2030) & (US$/Unit)
Figure 6. Glucose Injection Report Years Considered
Figure 7. Global Glucose Injection Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Glucose Injection Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucose Injection Revenue in 2023
Figure 10. Glucose Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 5% Injection Picture
Figure 12. 10% Injection Picture
Figure 13. 50% Injection Picture
Figure 14. 70% Injection Picture
Figure 15. Other Picture
Figure 16. Global Glucose Injection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Glucose Injection Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Glucose Injection Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Glucose Injection Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Glucose Injection Price by Type (2019-2030) & (US$/Unit)
Figure 21. Product Picture of Sports
Figure 22. Product Picture of First-Aid Treatment
Figure 23. Product Picture of Trophotherapy
Figure 24. Product Picture of Other
Figure 25. Global Glucose Injection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Glucose Injection Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Glucose Injection Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Glucose Injection Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Glucose Injection Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Glucose Injection Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Glucose Injection Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Glucose Injection Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Glucose Injection Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Glucose Injection Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Glucose Injection Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Glucose Injection Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Glucose Injection Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Glucose Injection Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Glucose Injection Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Glucose Injection Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Glucose Injection Sales Volume (%), (2019-2030)
Figure 42. United States Glucose Injection Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Glucose Injection Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Glucose Injection Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Glucose Injection Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Glucose Injection Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Glucose Injection Sales Value by Application (%), 2023 VS 2030
Figure 48. China Glucose Injection Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Glucose Injection Sales Value by Type (%), 2023 VS 2030
Figure 50. China Glucose Injection Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Glucose Injection Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Glucose Injection Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Glucose Injection Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Glucose Injection Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Glucose Injection Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Glucose Injection Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Glucose Injection Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Glucose Injection Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Glucose Injection Sales Value by Application (%), 2023 VS 2030
Figure 60. India Glucose Injection Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Glucose Injection Sales Value by Type (%), 2023 VS 2030
Figure 62. India Glucose Injection Sales Value by Application (%), 2023 VS 2030
Figure 63. Glucose Injection Industrial Chain
Figure 64. Glucose Injection Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
